Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
716 (USA) · Dr. Ito
consented 2012-07-09
AEs
3
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild EMPHYSEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-16 (study day 161.0); relationship: PROBABLE
moderate
assessed
Moderate NASOPHARYNGITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-20 (study day 43.0); relationship: NONE
moderate
assessed
Moderate NASOPHARYNGITIS — outcome: RECOVERED/RESOLVED; onset 2012-08-20 (study day 43.0); relationship: NONE
Data queries
No data queries.